This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
San Diego-based venture capital firm EnterprisePartners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics , Complete Genomics said today. Tags: illumina lifescience investment gene sequencing capital venture genomics complete partnersenterprise.
San Diego-based ecoATM , a developer of automated kiosks for recycling cell phones and other electronics, said this morning that it has raised a first institutional round of funding. The round came from TAO Venture Partners, the new venture firm run by Tom Clancy. Amount of funding was not disclosed. READ MORE>>.
Anzu Partners , a venture capital and private equity investors focused on industrial technology with offices in the San Diego area, has quietly raised $128.4M in its first venture capital fund. The company--which has offices in La Jolla, plus Massachusetts, Florida, and Washington, DC.--revealed READ MORE>>.
Details on the funding have not been announced by the company. Opthonix is venture backed by Cross Creek Capital, DAG Ventures, EnterprisePartners, Gund Investment Corp., Interwest Partners, Kleiner Perkins Caufield and Byers, Palo Alto Investors, Trex Enterprises, and Wasatch Advisors.
TargeGen had raised over $113M in venture funding from A.M. TargeGen's products are also potentially useful in treating certain forms of leukemia, lymphoma, other hematological malignancies and blood disorders.
was invested in 65 Southern California deals in Q3, compared to $773.3M billion invested in 637 deals in Q3, up 17 percent quarter-to-quarter, but down three percent in deals. round; San Diego-based Zogenix with a nearly $36M funding round; and Hawthorne-based Space Exploration Technology (SpaceX) , which raised $30.4M.
GTCR said the investment came from its $3.85 billion GTCR Fund XI, with additional funding provided by GE Capital and CapitalSource. XIFIN''s backers include Boulder Ventures, EnterprisePartners, and Windward Ventures. GTCR was advised by Kirkland & Ellis LLP in the deal. READ MORE>>.
A quick analysis by socalTECH of our tracking of venture capital deals in Southern California finds that there was around $879M in venture funding activity here in Q3. San Diego led investment activity in Q3, with a large number of the biggest VC deals all located in the area.
The round was led by Pfizer Venture Investments, and also included Lundbeckfond Ventures, Novartis Venture Funds, H&Q Healthcare/Life Sciences Investors, and GBS Venture Partners--all new investors--along with prior investors EnterprisePartners Venture Capital, Johnson & Johnson Development Corporation, and Venrock Associates.
Jvion , a developer of clinical decision support software, said on Thursday that it received a "significant" growth equity investment for the startup, to expand its healthcare AI and prescriptive analytics platform. The funding was led by JMI Equity, and also included Health EnterprisePartners (HEP) and Health Velocity Capital (HVC).
Other details on the funding have not been released, however, the firm is backed by EnterprisePartners and Vista Ventures, and Drew Senyei of Enterprise sits on the firm's board of directors. According to the firm's filing, the funding will go towards general working capital purposes and payroll.
in what it is calling a "Series AA" funding round. According to the firm, investors in the new round included Kleiner Perkins Caufield & Byers, EnterprisePartners, DAG Ventures, Gund Investment Corporation, InterWest Partners, Trex Enterprises and Wasatch Advisors' Cross Creek Capital Fund.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content